BMY
Bristol Myers Squibb's first quarter 2026 revenue grew 3% driven by a 12% increase in its Growth Portfolio.
Bristol Myers Squibb reported first quarter 2026 revenue of $11.5 billion, an increase of 3% year-over-year, while non-GAAP EPS declined 12% to $1.58. The...